Arnold J. Levine
17Patents
6h-index
35Co-inventors
66Inventor score
Filing activity: Jul 10, 1992 → Jun 15, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6020135A | P53-regulated genes | Chemistry; Metallurgy | 83 | Expired |
| US5382510A | Methods of diagnosing pre-cancer or cancer states using probes for detecting mutant p53 | Physics | 79 | Expired |
| US5674730A | Eukaryotic cells comprising a DNA sequence encoding a bacterial-viral chimeric transactivator protein | Chemistry; Metallurgy | 10 | Expired |
| US7899625B2 | Method and system for robust classification strategy for cancer detection from mass spectrometry data | Physics | 9 | Active |
| US6387657B1 | WISP polypeptides and nucleic acids encoding same | Chemistry; Metallurgy | 8 | Expired |
| US5843684A | Method for detecting pre-cancerous or cancerous cells using P90 antibodies or probes | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5620848A | Methods for detecting mutant p53 | Physics | 4 | Expired |
| US8731839B2 | Method and system for robust classification strategy for cancer detection from mass spectrometry data | Physics | 4 | Active |
| US7101850B2 | WISP polypeptides and nucleic acids encoding same | Chemistry; Metallurgy | 2 | Expired |
| US6489096B1 | Quantitative analysis of hybridization patterns and intensities in oligonucleotide arrays | Chemistry; Metallurgy | 0 | Expired |
| US7396533B2 | Polypeptides and nucleic acids encoding same | Chemistry; Metallurgy | 0 | Expired |
| US9422342B2 | Recoding method that removes inhibitory sequences and improves HIV gene expression | Chemistry; Metallurgy | 0 | Active |
| US7695962B2 | Polypeptides and nucleic acids encoding same | Chemistry; Metallurgy | 0 | Active |
| US10815277B2 | Viral inhibitory nucleotide sequences and vaccines | Chemistry; Metallurgy | 0 | Active |
| US8350008B2 | WISP polypeptides and nucleic acids encoding same | Chemistry; Metallurgy | 0 | Active |
| US11938124B2 | Combination therapy for treatment of cancer | Human Necessities | 0 | Active |
| US12331359B2 | Neoantigens and uses thereof for treating cancer | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.